Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Therapeutic Outcomes and Practices in Freeman-Sheldon Syndrome

NCT01144741 is registered in ClinicalTrials.gov with Freeman-Sheldon Research Group, Inc. as lead sponsor.

NCT NCT01144741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01144741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Therapeutic Outcomes and Practices in Freeman-Sheldon Syndrome
Lead sponsor
Freeman-Sheldon Research Group, Inc.
Phase
Observational
Overall status
Terminated
Start date
February 28, 2010
Completion date
June 14, 2022
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthrogryposis, arthrogryposis distal type 1, arthrogryposis distal type 1b, arthrogryposis distal type 2a, arthrogryposis distal type 2b, arthrogryposis distal type 3, arthrogryposis, distal, arthrogryposis, distal, type 1a, craniocarpotarsal dysplasia, craniocarpotarsal dystrophy, craniofacial abnormalities, freeman-sheldon syndrome, freeman-sheldon syndrome variant, gordon syndrome, sheldon-hall syndrome, whistling face syndrome